RPL22 Antibody

Référence MBS8582384-0,1mL-FITC

Conditionnement : 0.1mL(FITC)

Marque : MyBiosource

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

RPL22 Antibody – Rabbit Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8582384

MBS8582384 is an antibody targeting RPL22. Also known as RPL22 Antibody. Reactive in Human, Mouse, Rat, Chicken, Monkey, Pig. Host: Rabbit. Rabbit polyclonal antibody to RPL22 More details

Product Overview

Online Datasheet in PDF
Product Name
RPL22, Polyclonal Antibody
Full Product Name
RPL22 Antibody
Product Gene Name
anti-RPL22 antibody
Product Synonym Names
60S ribosomal protein L22; EBER-associated protein; EAP; Epstein-Barr virus small RNA-associated protein; Heparin-binding protein HBp15
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Chicken, Monkey, Pig
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of RPL22 protein.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Molecular Weight
14,787 Da
Chromosome Location
Chromosome: 1; NC_000001.10 (6245080..6259679, complement). Location: 1p36.31
OMIM
180474
3D Structure
ModBase 3D Structure for P35268
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the center region of human RPL22. The exact sequence is proprietary.

Product Categories/Family for anti-RPL22 antibody

Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-RPL22 antibody
Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-RPL22 antibody
WB: 1:500-1:1000
IHC: 1:50-1:200

Other Notes

Small volumes of anti-RPL22 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for RPL22. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
60S ribosomal protein L22 proprotein
NCBI Official Synonym Full Names
ribosomal protein L22
NCBI Official Symbol
RPL22
NCBI Official Synonym Symbols
EAP; L22; HBP15; HBP15/L22
UniProt Protein Name
60S ribosomal protein L22
UniProt Synonym Protein Names
EBER-associated protein; EAP; Epstein-Barr virus small RNA-associated protein; Heparin-binding protein HBp15
Protein Family
50S ribosomal protein
UniProt Gene Name
RPL22
UniProt Synonym Gene Names
EAP
UniProt Entry Name
RL22_HUMAN
NCBI Protein Information
60S ribosomal protein L22; EBER-associated protein; heparin-binding protein 15; heparin-binding protein HBp15; Epstein-Barr-encoded RNA-associated protein; Epstein-Barr virus small RNA-associated protein

NCBI Summary for RPL22

Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a cytoplasmic ribosomal protein that is a component of the 60S subunit. The protein belongs to the L22E family of ribosomal proteins. Its initiating methionine residue is post-translationally removed. The protein can bind specifically to Epstein-Barr virus-encoded RNAs (EBERs) 1 and 2. The mouse protein has been shown to be capable of binding to heparin. Transcript variants utilizing alternative polyA signals exist. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. It was previously thought that this gene mapped to 3q26 and that it was fused to the acute myeloid leukemia 1 (AML1) gene located at 21q22 in some therapy-related myelodysplastic syndrome patients with 3;21 translocations; however, these fusions actually involve a ribosomal protein L22 pseudogene located at 3q26, and this gene actually maps to 1p36.3-p36.2. [provided by RefSeq, Jul 2008]
Show more

UniProt Comments for RPL22

RPL22: a cytoplasmic ribosomal protein that is a component of the 60S subunit. The protein belongs to the L22E family of ribosomal proteins. Its initiating methionine residue is post-translationally removed. The protein can bind specifically to Epstein-Barr virus-encoded RNAs (EBERs) 1 and 2. The mouse protein has been shown to be capable of binding to heparin. Transcript variants utilizing alternative polyA signals exist. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. It was previously thought that this gene mapped to 3q26 and that it was fused to the acute myeloid leukemia 1 (AML1) gene located at 21q22 in some therapy-related myelodysplastic syndrome patients with 3;21 translocations; however, these fusions actually involve a ribosomal protein L22 pseudogene located at 3q26, and this gene actually maps to 1p36.3-p36.2. [provided by RefSeq, Jul 2008]

Protein type: RNA-binding

Chromosomal Location of Human Ortholog: 1p36.31

Cellular Component: focal adhesion; cytoplasm; cytosol; nucleus; ribonucleoprotein complex

Molecular Function: heparin binding; protein binding; structural constituent of ribosome; RNA binding

Biological Process: SRP-dependent cotranslational protein targeting to membrane; translational elongation; cellular protein metabolic process; viral reproduction; translation; mRNA catabolic process, nonsense-mediated decay; translational initiation; alpha-beta T cell differentiation; gene expression; viral transcription; viral infectious cycle; translational termination
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Pathways associated with anti-RPL22 antibody

 Products by Pathway  Pathway Diagram
 Cap-dependent Translation Initiation Pathway antibodies  Cap-dependent Translation Initiation Pathway Diagram
 Cytoplasmic Ribosomal Proteins Pathway antibodies  Cytoplasmic Ribosomal Proteins Pathway Diagram
 Disease Pathway antibodies  Disease Pathway Diagram
 Eukaryotic Translation Elongation Pathway antibodies  Eukaryotic Translation Elongation Pathway Diagram
 Eukaryotic Translation Initiation Pathway antibodies  Eukaryotic Translation Initiation Pathway Diagram
 Eukaryotic Translation Termination Pathway antibodies  Eukaryotic Translation Termination Pathway Diagram
 Formation Of A Pool Of Free 40S Subunits Pathway antibodies  Formation Of A Pool Of Free 40S Subunits Pathway Diagram
 GTP Hydrolysis And Joining Of The 60S Ribosomal Subunit Pathway antibodies  GTP Hydrolysis And Joining Of The 60S Ribosomal Subunit Pathway Diagram
 Gene Expression Pathway antibodies  Gene Expression Pathway Diagram
 Influenza Infection Pathway antibodies  Influenza Infection Pathway Diagram

Diseases associated with anti-RPL22 antibody

 Disease Name  Pubmed Publications
 Neoplasms Antibodies  >120 publications with RPL22 and Neoplasms
 Lymphoma Antibodies  >74 publications with RPL22 and Lymphoma
 Neoplasms, Experimental Antibodies  >55 publications with RPL22 and Neoplasms, Experimental
 Carcinoma Antibodies  >40 publications with RPL22 and Carcinoma
 Adenocarcinoma Antibodies  >10 publications with RPL22 and Adenocarcinoma
 Bone Diseases Antibodies  >7 publications with RPL22 and Bone Diseases
 Necrosis Antibodies  >7 publications with RPL22 and Necrosis
 Liver Diseases Antibodies  >5 publications with RPL22 and Liver Diseases
 Liver Neoplasms Antibodies  >4 publications with RPL22 and Liver Neoplasms
 Inflammation Antibodies  >3 publications with RPL22 and Inflammation

Organs/Tissues associated with anti-RPL22 antibody

 Organ/Tissue Name  Pubmed Publications
 Blood Antibodies  >45 publications with RPL22 and Blood
 Lymph Node Antibodies  >16 publications with RPL22 and Lymph Node
 Lymph Antibodies  >15 publications with RPL22 and Lymph
 Liver Antibodies  >15 publications with RPL22 and Liver
 Stomach Antibodies  >10 publications with RPL22 and Stomach
 Brain Antibodies  >10 publications with RPL22 and Brain
 Skin Antibodies  >6 publications with RPL22 and Skin
 Spleen Antibodies  >5 publications with RPL22 and Spleen
 Thymus Antibodies  >4 publications with RPL22 and Thymus
 Lung Antibodies  >4 publications with RPL22 and Lung